[Form 3/A] Lifevantage Corp Amended Initial Statement of Beneficial Ownership

Q: What did LifeVantage (LFVN) update in this Form 3/A?

It corrected the officer’s holdings to 51,330 common shares and added 16,491 PRSUs granted on August 26, 2025 .

Q: Who is the reporting person in LFVN’s Form 3/A amendment?

Todd Thompson, Chief Information Officer of LifeVantage.

Q: What derivative awards are disclosed for LFVN’s officer?

Two PRSU grants: 3,750 (granted Dec 23, 2024 ) and 16,491 (granted Aug 26, 2025 ), each representing one share per unit at target.

Q: What are the vesting schedules for the PRSUs?

2024 grant: 50% on Aug 31, 2025 ; 30% on Aug 31, 2026 ; 20% on Aug 31, 2027 . 2025 grant: 34% on Sep 10, 2026 ; 33% on Sep 10, 2027 ; 33% on Sep 10, 2028 , subject to performance and service.

Q: What additional exhibit was included in the amendment?

The filing adds Exhibit 24 – Power of Attorney .

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

3/A

Rhea-AI Filing Summary

LifeVantage (LFVN)51,330 shares and adds 16,491 performance RSUs granted on August 26, 2025. The original reported 40,336 shares and omitted this PRSU grant.

It also lists 3,750 PRSUs granted on December 23, 2024. Vesting for the 2024 grant: 50% on August 31, 2025; 30% on August 31, 2026; 20% on August 31, 2027, subject to performance and continued service. The 2025 grant vests 34% on September 10, 2026; 33% on September 10, 2027; and 33% on September 10, 2028. The amendment adds Exhibit 24, Power of Attorney.

LifeVantage (LFVN) ha depositato una modifica Form 3/A per l'ufficiale Todd Thompson, Chief Information Officer, aggiornando le sue partecipazioni aventi diritto. Il deposito corregge la proprietà di azioni ordinarie a 51.330 azioni e aggiunge 16.491 RSU di performance concesse il 26 agosto 2025. L'originale riportava 40.336 azioni e ometteva questa concessione PRSU.
Riporta anche 3.750 PRSU concesse il 23 dicembre 2024. Vesting per la concessione del 2024: 50% il 31 agosto 2025; 30% il 31 agosto 2026; 20% il 31 agosto 2027, soggetto a performance e al continuato servizio. La concessione del 2025 matura 34% il 10 settembre 2026; 33% il 10 settembre 2027; e 33% il 10 settembre 2028. La modifica aggiunge l'Esibizione 24, Procura.

LifeVantage (LFVN) ha presentado una enmienda Form 3/A para el oficial Todd Thompson, Director de Información, actualizando sus participaciones beneficiosas. El depósito corrige la propiedad de acciones comunes a 51.330 acciones y añade 16.491 RSU de rendimiento concedidas el 26 de agosto de 2025. El informe original reportaba 40.336 acciones y omitía esta concesión PRSU.
También lista 3.750 PRSU concedidas el 23 de diciembre de 2024. Vencimiento para la concesión de 2024: 50% el 31 de agosto de 2025; 30% el 31 de agosto de 2026; 20% el 31 de agosto de 2027, sujeto a desempeño y servicio continuo. La concesión de 2025 vence 34% el 10 de septiembre de 2026; 33% el 10 de septiembre de 2027; y 33% el 10 de septiembre de 2028. La enmienda añade el Exhibit 24, Power of Attorney.

LifeVantage (LFVN)가 Todd Thompson 임원, CIO를 위한 Form 3/A 수정안을 제출하여 그의 수혜 보유를 업데이트했습니다. 이 제출은 보통주 소유를 51,330주로 정정하고 16,491 성과 RSU를 2025년 8월 26일에 부여된 것으로 추가합니다. 원래 보고된 주식 수는 40,336주였고 이 PRSU 부여는 누락되었습니다.
또한 3,750 PRSU가 2024년 12월 23일에 부여되었다고 명시합니다. 2024년 부여의 귀속은: 2025년 8월 31일에 50%, 2026년 8월 31일에 30%, 2027년 8월 31일에 20%, 성과 및 지속적인 서비스에 따라 달라집니다. 2025년 부여는 2026년 9월 10일에 34%, 2027년 9월 10일에 33%, 2028년 9월 10일에 33%로 귀속됩니다. 수정안에는 Exhibit 24, Power of Attorney가 추가됩니다.

LifeVantage (LFVN) a déposé un amendement Form 3/A pour l'officier Todd Thompson, directeur des informations, mettant à jour ses participations bénéficiaires. Le dépôt corrige la propriété d'actions ordinaires à 51 330 actions et ajoute 16 491 RSU de performance accordées le 26 août 2025. Le dépôt original indiquait 40 336 actions et omettait cette attribution PRSU.
Il répertorie également 3 750 PRSU accordées le 23 décembre 2024. Le vesting de la subvention 2024 est: 50 % le 31 août 2025; 30 % le 31 août 2026; 20 % le 31 août 2027, sous réserve de performance et de service continu. La subvention 2025 mue à 34 % le 10 septembre 2026; 33 % le 10 septembre 2027; et 33 % le 10 septembre 2028. L'amendement ajoute l'Exhibit 24, Power of Attorney.

LifeVantage (LFVN) hat eine Form 3/A-Änderung für den Beamten Todd Thompson, Chief Information Officer, eingereicht und seine wirtschaftlich berechtigten Anteile aktualisiert. Die Einreichung korrigiert den Besitz von Stammaktien auf 51.330 Aktien und fügt 16.491 Performance RSUs hinzu, die am 26. August 2025 gewährt wurden. Die ursprüngliche Meldung meldete 40.336 Aktien und ließ diese PRSU-Zuteilung aus.
Sie listet außerdem 3.750 PRSUs auf, die am 23. Dezember 2024 gewährt wurden. Die Vesting-Regelung für 2024: 50% am 31. August 2025; 30% am 31. August 2026; 20% am 31. August 2027, vorbehaltlich Leistung und fortgesetztem Dienst. Die Zuteilung 2025 vestet zu 34% am 10. September 2026; 33% am 10. September 2027; und 33% am 10. September 2028. Die Änderung fügt Exhibit 24, Power of Attorney, hinzu.

LifeVantage (LFVN) قدمت تعديل Form 3/A للضابط Todd Thompson، المدير التنفيذي للمعلومات، لتحديث حصصه المستفيدة. يصحح الإبلاغ ملكية الأسهم العادية إلى 51,330 سهمًا ويضيف 16,491 RSU للأداء الممنوحة في 26 أغسطس 2025. كان التقرير الأصلي قد ذكر 40,336 سهمًا وحُذِف هذا المنح PRSU.
ويذكر أيضاً 3,750 PRSU ممنوحة في 23 ديسمبر 2024. تشطيب (vesting) من منح 2024: 50% في 31 أغسطس 2025؛ 30% في 31 أغسطس 2026؛ 20% في 31 أغسطس 2027، مع شرط الأداء والاستمرار بالخدمة. منح 2025 تُستحق 34% في 10 سبتمبر 2026؛ 33% في 10 سبتمبر 2027؛ و33% في 10 سبتمبر 2028. التعديل يضيف Exhibit 24، Power of Attorney.

LifeVantage (LFVN) 已就高管 Todd Thompson，首席信息官，提交 Form 3/A 修订案，更新其受益持股。该备案将普通股持有量更正为 51,330 股，并新增 16,491 股绩效 RSU，授予日为 2025 年 8 月 26 日。原报告为 40,336 股，且未包含此次 PRSU 授予。
另列出 3,750 PRSU，授予日期为 2024 年 12 月 23 日。2024 年 grant 的归属：2025 年 8 月 31 日 50%；2026 年 8 月 31 日 30%；2027 年 8 月 31 日 20%，须受业绩与持续服务条件限制。2025 年 grant 的归属为 34% 于 2026 年 9 月 10 日；33% 于 2027 年 9 月 10 日；33% 于 2028 年 9 月 10 日。修订案还新增 Exhibit 24，Power of Attorney。

Positive

None.

Negative

None.

10/15/2025 - 05:04 PM

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0104

Estimated average burden

hours per response: 0.5

1. Name and Address of Reporting Person^*
Thompson Todd

(Last) (First) (Middle)

3300 N. TRIUMPH BLVD

SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/12/2025 3. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director 10% Owner

X Officer (give title below) Other (specify below)

Chief Information Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
10/03/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Common Stock 51,330⁽¹⁾ D

Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)

Date Exercisable Expiration Date Title Amount or Number of Shares

Performance Restricted Stock Units⁽²⁾ ⁽³⁾ ⁽³⁾ Common Stock 3,750 ⁽³⁾ D

Performance Restricted Stock Units⁽²⁾ ⁽⁴⁾ ⁽⁴⁾ Common Stock 16,491⁽¹⁾ ⁽⁴⁾ D

Explanation of Responses:

1. This Form 3/A is being filed to correct the number of shares of common stock and Performance Restricted Stock Units ("PRSU") reported in Tables I and II, respectively, of the original Form 3 filed on October 3, 2025. Table I inadvertently reported 40,336 shares of common stock beneficially owned by the reporting person instead of the 51,330 shares reported herein. Table II inadvertently omitted 16,491 PRSUs granted to the reporting person on August 26, 2025, reported herein.

2. Each PRSU represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.

3. The PRSUs were granted on December 23, 2024. The number reported reflects the unvested PRSUs remaining under such grant. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows (i) 50% of the earned award vested on August 31, 2025 (ii) 30% of the earned award will vest on August 31, 2026 and (iii) 20% of the earned award will vest on August 31, 2027.

4. The PRSUs were granted on August 26, 2025. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.

Remarks:

The Form 3 filed on October 3, 2025 is amended to include Exhibit 24 - Power of Attorney.

/s/ Alissa Neufeld, Power of Attorney for Todd Thompson 10/15/2025

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did LifeVantage (LFVN) update in this Form 3/A?

It corrected the officer’s holdings to 51,330 common shares and added 16,491 PRSUs granted on August 26, 2025.

Who is the reporting person in LFVN’s Form 3/A amendment?

Todd Thompson, Chief Information Officer of LifeVantage.

What derivative awards are disclosed for LFVN’s officer?

Two PRSU grants: 3,750 (granted Dec 23, 2024) and 16,491 (granted Aug 26, 2025), each representing one share per unit at target.

What are the vesting schedules for the PRSUs?

2024 grant: 50% on Aug 31, 2025; 30% on Aug 31, 2026; 20% on Aug 31, 2027. 2025 grant: 34% on Sep 10, 2026; 33% on Sep 10, 2027; 33% on Sep 10, 2028, subject to performance and service.

Does the Form 3/A mention performance multipliers?

Yes. Upon maximum performance, the reporting person may earn up to 200% of the target number of PRSUs.

What additional exhibit was included in the amendment?

The filing adds Exhibit 24 – Power of Attorney.

[Form 3/A] Lifevantage Corp Amended Initial Statement of Beneficial Ownership

FAQ

What did LifeVantage (LFVN) update in this Form 3/A?

Who is the reporting person in LFVN’s Form 3/A amendment?

What derivative awards are disclosed for LFVN’s officer?

What are the vesting schedules for the PRSUs?

Does the Form 3/A mention performance multipliers?

What additional exhibit was included in the amendment?

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	51,330⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Performance Restricted Stock Units⁽²⁾	⁽³⁾	⁽³⁾	Common Stock	3,750	⁽³⁾	D
Performance Restricted Stock Units⁽²⁾	⁽⁴⁾	⁽⁴⁾	Common Stock	16,491⁽¹⁾	⁽⁴⁾	D

	/s/ Alissa Neufeld, Power of Attorney for Todd Thompson	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Trending News

[Form 3/A] Lifevantage Corp Amended Initial Statement of Beneficial Ownership

FAQ

What did LifeVantage (LFVN) update in this Form 3/A?

Who is the reporting person in LFVN’s Form 3/A amendment?

What derivative awards are disclosed for LFVN’s officer?

What are the vesting schedules for the PRSUs?

Does the Form 3/A mention performance multipliers?

What additional exhibit was included in the amendment?

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data